vs
INVO Fertility, Inc.（IVF）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
INVO Fertility, Inc.的季度营收约是Arcadia Biosciences, Inc.的2.0倍（$1.8M vs $901.0K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -150.5%，领先2.2%），INVO Fertility, Inc.同比增速更快（22.6% vs -25.8%），过去两年INVO Fertility, Inc.的营收复合增速更高（12.8% vs -4.5%）
INVO Fertility是一家专注于辅助生殖医疗解决方案的企业，核心产品为专利INVOcell阴道内培养装置，服务北美、欧洲等地区的生殖诊所与患者，致力于降低生育治疗门槛，为有需求的群体提供可负担的生殖医疗服务。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
IVF vs RKDA — 直观对比
营收规模更大
IVF
是对方的2.0倍
$901.0K
营收增速更快
IVF
高出48.4%
-25.8%
净利率更高
RKDA
高出2.2%
-150.5%
两年增速更快
IVF
近两年复合增速
-4.5%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8M | $901.0K |
| 净利润 | $-2.6M | $-1.3M |
| 毛利率 | — | 21.4% |
| 营业利润率 | -93.1% | -152.8% |
| 净利率 | -150.5% | -148.3% |
| 营收同比 | 22.6% | -25.8% |
| 净利润同比 | -62.2% | 67.1% |
| 每股收益（稀释后） | $-0.77 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IVFRKDA
| Q4 25 | — | $901.0K | ||
| Q3 25 | $1.8M | $1.3M | ||
| Q2 25 | $1.9M | $1.5M | ||
| Q1 25 | $1.6M | $1.2M | ||
| Q4 24 | $1.7M | $1.2M | ||
| Q3 24 | $1.4M | $1.5M | ||
| Q2 24 | $1.8M | $1.3M | ||
| Q1 24 | $1.6M | $987.0K |
净利润IVFRKDA
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-2.6M | $856.0K | ||
| Q2 25 | $-5.3M | $-4.5M | ||
| Q1 25 | $-17.4M | $2.6M | ||
| Q4 24 | $-3.6M | $-4.1M | ||
| Q3 24 | $-1.6M | $-1.6M | ||
| Q2 24 | $-2.2M | $1.1M | ||
| Q1 24 | $-1.6M | $-2.4M |
毛利率IVFRKDA
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | 35.2% | 43.2% | ||
| Q4 24 | 41.4% | 31.9% | ||
| Q3 24 | 31.0% | 32.9% | ||
| Q2 24 | 53.1% | 51.5% | ||
| Q1 24 | 45.3% | 52.3% |
营业利润率IVFRKDA
| Q4 25 | — | -152.8% | ||
| Q3 25 | -93.1% | -88.5% | ||
| Q2 25 | -160.4% | -34.4% | ||
| Q1 25 | -1042.1% | 44.2% | ||
| Q4 24 | -202.0% | -187.7% | ||
| Q3 24 | -90.7% | -114.5% | ||
| Q2 24 | -100.9% | — | ||
| Q1 24 | -95.7% | -160.9% |
净利率IVFRKDA
| Q4 25 | — | -148.3% | ||
| Q3 25 | -150.5% | 65.7% | ||
| Q2 25 | -283.6% | -306.4% | ||
| Q1 25 | -1060.1% | 216.6% | ||
| Q4 24 | -211.3% | -334.5% | ||
| Q3 24 | -113.8% | -104.9% | ||
| Q2 24 | -122.2% | 81.2% | ||
| Q1 24 | -101.3% | -245.5% |
每股收益（稀释后）IVFRKDA
| Q4 25 | — | $-0.97 | ||
| Q3 25 | $-0.77 | $0.62 | ||
| Q2 25 | $-13.30 | $-3.26 | ||
| Q1 25 | $-12.53 | $1.90 | ||
| Q4 24 | $14.86 | $-2.99 | ||
| Q3 24 | $-15.11 | $-1.18 | ||
| Q2 24 | $-22.39 | $0.78 | ||
| Q1 24 | $-7.55 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $4.6M |
| 总债务越低越好 | $2.0M | — |
| 股东权益账面价值 | $5.8M | $4.1M |
| 总资产 | $18.8M | $6.5M |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势，按日历期对齐
现金及短期投资IVFRKDA
| Q4 25 | — | $4.6M | ||
| Q3 25 | — | $5.9M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $3.2M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | — | $6.6M | ||
| Q2 24 | — | $8.1M | ||
| Q1 24 | — | $8.5M |
总债务IVFRKDA
| Q4 25 | — | — | ||
| Q3 25 | $2.0M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $7.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IVFRKDA
| Q4 25 | — | $4.1M | ||
| Q3 25 | $5.8M | $5.4M | ||
| Q2 25 | $2.6M | $4.5M | ||
| Q1 25 | $3.3M | $8.9M | ||
| Q4 24 | $12.7M | $6.2M | ||
| Q3 24 | $-23.3K | $10.3M | ||
| Q2 24 | $1.4M | $11.7M | ||
| Q1 24 | $10.2K | $10.6M |
总资产IVFRKDA
| Q4 25 | — | $6.5M | ||
| Q3 25 | $18.8M | $8.6M | ||
| Q2 25 | $19.3M | $7.8M | ||
| Q1 25 | $31.7M | $13.0M | ||
| Q4 24 | $46.4M | $13.5M | ||
| Q3 24 | $17.0M | $15.2M | ||
| Q2 24 | $17.8M | $17.4M | ||
| Q1 24 | $17.3M | $16.0M |
负债/权益比IVFRKDA
| Q4 25 | — | — | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 1.83× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.8M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -101.6% | — |
| 资本支出强度资本支出/营收 | 0.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-7.8M | — |
8季度趋势，按日历期对齐
经营现金流IVFRKDA
| Q4 25 | — | $-861.0K | ||
| Q3 25 | $-1.8M | $-257.0K | ||
| Q2 25 | $-1.7M | $-2.0M | ||
| Q1 25 | $-3.5M | $-1.6M | ||
| Q4 24 | $-617.4K | $-2.2M | ||
| Q3 24 | $-640.8K | $-1.8M | ||
| Q2 24 | $-1.5M | $-2.5M | ||
| Q1 24 | $-260.6K | $-3.2M |
自由现金流IVFRKDA
| Q4 25 | — | — | ||
| Q3 25 | $-1.8M | — | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-3.6M | — | ||
| Q4 24 | $-696.3K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-1.5M | $-2.5M | ||
| Q1 24 | $-310.3K | $-3.2M |
自由现金流率IVFRKDA
| Q4 25 | — | — | ||
| Q3 25 | -101.6% | — | ||
| Q2 25 | -92.6% | — | ||
| Q1 25 | -216.9% | — | ||
| Q4 24 | -40.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -82.3% | -188.3% | ||
| Q1 24 | -19.7% | -326.5% |
资本支出强度IVFRKDA
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.5% | 0.0% | ||
| Q2 25 | 0.5% | 0.0% | ||
| Q1 25 | 0.9% | 0.0% | ||
| Q4 24 | 4.6% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 3.0% | 0.2% | ||
| Q1 24 | 3.2% | 1.3% |
现金转化率IVFRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
